The Board proposes the development of rule amendments to address the appropriate standards for the use of controlled substances for the treatment of pain.

DEPARTMENT OF HEALTH
Board of Osteopathic Medicine

Rule No.: RULE TITLE
64B15-14.005: Standards for the Use of Controlled Substances for Treatment of Pain
PURPOSE AND EFFECT: The Board proposes the development of rule amendments to address the appropriate standards for the use of controlled substances for the treatment of pain.
SUBJECT AREA TO BE ADDRESSED: Appropriate standards for the use of controlled substances for the treatment of pain.
SPECIFIC AUTHORITY: 459.005(1) FS.
LAW IMPLEMENTED: 459.003(3), 459.015(1)(g), (x) FS.
IF REQUESTED IN WRITING AND NOT DEEMED UNNECESSARY BY THE AGENCY HEAD, A RULE DEVELOPMENT WORKSHOP WILL BE NOTICED IN THE NEXT AVAILABLE FLORIDA ADMINISTRATIVE WEEKLY.
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE DEVELOPMENT AND A COPY OF THE PRELIMINARY DRAFT, IF AVAILABLE, IS: Anthony Jusevitch, Executive Director, Board of Osteopathic Medicine/MQA, 4052 Bald Cypress Way, Bin #C06, Tallahassee, Florida 32399-3256

THE PRELIMINARY TEXT OF THE PROPOSED RULE DEVELOPMENT IS NOT AVAILABLE.